Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Lymphoid 1Head & Neck 1Dermatologic 1

Conditions

Pancreatic Neoplasms 57Carcinoma, Non-Small-Cell Lung 30Breast Neoplasms 26Neoplasms 24Neoplasm Metastasis 24Triple Negative Breast Neoplasms 21Parkinson Disease 4, Autosomal Dominant Lewy Body 10Lung Neoplasms 9Melanoma 8Stomach Neoplasms 7Carcinoma, Pancreatic Ductal 7Adenocarcinoma 7Ovarian Neoplasms 6Colorectal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Esophageal Neoplasms 4Digestive System Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma 3Recurrence 3Rectal Neoplasms 3Pancreatic Diseases 3Neoplasms by Site 3Lymphoma, Non-Hodgkin 3Fallopian Tube Neoplasms 3Endometrial Neoplasms 3Endocrine Gland Neoplasms 3Digestive System Diseases 3

Interventions

pembrolizumab 20Cisplatin 17Cetuximab 13Docetaxel 11Paclitaxel 9Carboplatin 9Radiotherapy 8Fluorouracil 6cemiplimab 5130-nm albumin-bound paclitaxel 5Bleomycin 4Radiation 3Pemetrexed 3Panitumumab 3Nivolumab 3Gemcitabine 3Albumin-Bound Paclitaxel 3vandetanib 2talimogene laherparepvec 2selinexor 2motexafin gadolinium 2figitumumab 2brigatinib 2avelumab 2atezolizumab 2alpha-2'-deoxythioguanosine 2advexin 2Taxes 2ON 01910 2Methotrexate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Squamous Cell × Albumin-Bound Paclitaxel × Clear all
NCT02376699 2023-05-01

Safety Study of SEA-CD40 in Cancer Patients

Seagen Inc.

Phase 1 Terminated
159 enrolled
DermatologicHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasms, Squamous Cell

NCT02027428 2020-08-17

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Celgene

Phase 3 Completed
427 enrolled 29 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms

NCT02151149 2018-09-24

ABOUND 70+

Celgene

Phase 4 Completed
143 enrolled 25 charts
Thoracic

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡